Clinical Trial Update: A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR) [Phase 3]

View source ↗

Summary

Phase 3 METEOR trial evaluated rosuvastatin 40 mg for effects on carotid intima-media thickness in hypercholesterolemia. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• CRESTOR (Rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesteremia | Phase 3 | Status: COMPLETED